A new trading day began on November 20, 2023, with vTv Therapeutics Inc (NASDAQ: VTVT) stock priced at $15.20, down -5.71% from the previous day of trading. During the day, the shares moved up to $15.20 and dropped to $14.00 before settling in for the closing price of $0.37. VTVT’s price has ranged from $0.35 to $1.05 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 827.99%. With a float of $26.64 million, this company’s outstanding shares have now reached $81.48 million.
Let’s determine the extent of company efficiency that accounts for 13 employees. In terms of profitability, gross margin is +95.44, operating margin of -1116.95, and the pretax margin is -1232.56.
vTv Therapeutics Inc (VTVT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of vTv Therapeutics Inc is 67.31%, while institutional ownership is 2.22%. The most recent insider transaction that took place on Nov 29, was worth 33,773. In this transaction Director of this company bought 40,461 shares at a rate of $0.83, taking the stock ownership to the 61,000 shares. Before that another transaction happened on Nov 28, when Company’s Director bought 20,539 for $0.83, making the entire transaction worth $16,969. This insider now owns 20,539 shares in total.
vTv Therapeutics Inc (VTVT) Recent Fiscal highlights
In its latest quarterly report, released on 3/30/2023, the company reported earnings of -$0.06 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -949.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
vTv Therapeutics Inc (NASDAQ: VTVT) Trading Performance Indicators
Here are vTv Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2851.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26
Technical Analysis of vTv Therapeutics Inc (VTVT)
Looking closely at vTv Therapeutics Inc (NASDAQ: VTVT), its last 5-days average volume was 0.21 million, which is a jump from its year-to-date volume of 0.13 million. As of the previous 9 days, the stock’s Stochastic %D was 20.44%. Additionally, its Average True Range was 0.03.
During the past 100 days, vTv Therapeutics Inc’s (VTVT) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.17% in the past 14 days, which was lower than the 61.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4325, while its 200-day Moving Average is $0.6754. However, in the short run, vTv Therapeutics Inc’s stock first resistance to watch stands at $0.3700. Second resistance stands at $0.3900. The third major resistance level sits at $0.4000. If the price goes on to break the first support level at $0.3400, it is likely to go to the next support level at $0.3300. Now, if the price goes above the second support level, the third support stands at $0.3100.
vTv Therapeutics Inc (NASDAQ: VTVT) Key Stats
With a market capitalization of 28.52 million, the company has a total of 104,577K Shares Outstanding. Currently, annual sales are 2,020 K while annual income is -19,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,650 K.